title: Potential biofluid markers and treatment targets for renal cell carcinoma.
abstract: Renal cell carcinoma (RCC) is the 13th most common cancer in the world and one of the few cancers for which incidence is increasing. This disease is generally asymptomatic at an early stage and is highly metastatic. Frequently discovered by physicians in the process of working up other diseases such as acute kidney injury, RCC is often discovered in an advanced form and many patients have metastases at the time of diagnosis. Given that life expectancy with currently approved therapies for metastatic RCC is approximately 1-2 years, biomarkers for RCC that will enable early detection are urgently needed. Although it is unlikely that highly sensitive and specific biomarkers will be identified in the near future that are useful for screening the general population, a noninvasive marker or set of markers could soon be used in general medicine, nephrology, and urology clinics to screen patients at increased risk of RCC. In addition to the ongoing need for RCC biomarkers, the frequent resistance reported with currently available targeted therapies makes the identification of new therapeutic targets similarly important. Many promising leads for new targeted therapies have come to light; some of these therapies are in clinical trials and others are still being evaluated in the laboratory.
authors.affiliation: Division of Nephrology, University of California, Davis, CA 95616, USA.
authors.forename: Hiromi I
authors.initials: HI
authors.lastname: Wettersten
authors.forename: Robert H
authors.initials: RH
authors.lastname: Weiss
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000378:metabolism*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor
references.citation: Clin Cancer Res. 2007 Mar 15;13(6):1757-61
references.pmid: 17363529
references.citation: J Immunol. 2009 Dec 15;183(12):7752-60
references.pmid: 19933867
references.citation: Cancer Res. 2004 Oct 1;64(19):7099-109
references.pmid: 15466206
references.citation: Cell. 1996 Nov 15;87(4):619-28
references.pmid: 8929531
references.citation: J Transl Med. 2012 Mar 22;10:55
references.pmid: 22440013
references.citation: Mol Cancer Ther. 2012 Mar;11(3):526-37
references.pmid: 22351744
references.citation: Endocrinology. 2010 Jan;151(1):123-33
references.pmid: 19887568
references.citation: J Urol. 1997 Apr;157(4):1482-6
references.pmid: 9120987
references.citation: Cancer Res. 2000 Apr 1;60(7):1942-8
references.pmid: 10766184
references.citation: Anticancer Agents Med Chem. 2010 Jan;10(1):7-27
references.pmid: 20015007
references.citation: EMBO J. 2010 Jun 16;29(12):2002-13
references.pmid: 20485264
references.citation: Cancer Chemother Pharmacol. 2011 Jun;67(6):1369-80
references.pmid: 20803015
references.citation: J Urol. 2008 Jul;180(1):352-60
references.pmid: 18499163
references.citation: Clin Cancer Res. 2007 Dec 15;13(24):7388-93
references.pmid: 18094421
references.citation: Cell Signal. 2010 Jul;22(7):1003-12
references.pmid: 20100570
references.citation: Int J Cancer. 2005 Mar 10;114(1):101-8
references.pmid: 15523697
references.citation: Clin Cancer Res. 2010 Mar 1;16(5):1634-41
references.pmid: 20179242
references.citation: Mol Cell. 2010 Mar 12;37(5):620-32
references.pmid: 20227367
references.citation: Cancer Lett. 2008 Sep 28;269(1):7-17
references.pmid: 18462867
references.citation: N Engl J Med. 2012 Jun 28;366(26):2455-65
references.pmid: 22658128
references.citation: Curr Med Chem. 2008;15(26):2648-55
references.pmid: 18991627
references.citation: Clin Cancer Res. 2008 Aug 1;14(15):4726-34
references.pmid: 18676741
references.citation: Mol Cell Pharmacol. 2011;3(3):83-92
references.pmid: 22468167
references.citation: Gynecol Oncol. 2009 Jan;112(1):55-9
references.pmid: 18954897
references.citation: Expert Opin Investig Drugs. 2007 Jul;16(7):1111-20
references.pmid: 17594194
references.citation: Cancer Lett. 2012 Mar 28;316(2):196-203
references.pmid: 22169097
references.citation: Kidney Int. 2006 Jan;69(2):224-32
references.pmid: 16408110
references.citation: Clin Adv Hematol Oncol. 2010 May;8(5):357-60, 361-4
references.pmid: 20551895
references.citation: Clin Cancer Res. 2013 Mar 1;19(5):1257-68
references.pmid: 23339124
references.citation: Am J Physiol Renal Physiol. 2004 Mar;286(3):F552-63
references.pmid: 14600030
references.citation: Clin Cancer Res. 2006 May 15;12(10):3028-36
references.pmid: 16707598
references.citation: J Urol. 2013 Jun;189(6):2317-26
references.pmid: 23079374
references.citation: Clin Cancer Res. 2010 Jan 1;16(1):141-53
references.pmid: 20028765
references.citation: J Biomed Biotechnol. 2010;2010:
references.pmid: 20798865
references.citation: Nat Rev Cancer. 2004 Sep;4(9):718-27
references.pmid: 15343278
references.citation: N Engl J Med. 2012 Jun 28;366(26):2443-54
references.pmid: 22658127
references.citation: Blood. 2011 Oct 6;118(14):3922-31
references.pmid: 21841164
references.citation: J Mol Med (Berl). 2005 Oct;83(10):774-85
references.pmid: 15976920
references.citation: Electrophoresis. 2009 Dec;30(23):4152-62
references.pmid: 19960480
references.citation: J Clin Oncol. 2012 Jul 1;30(19):2348-53
references.pmid: 22529266
references.citation: J Hematol Oncol. 2010 Feb 04;3:5
references.pmid: 20132536
references.citation: J Mol Med (Berl). 2008 Feb;86(2):145-60
references.pmid: 17876564
references.citation: Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9700-4
references.pmid: 7937876
references.citation: Nat Rev Drug Discov. 2002 Aug;1(8):609-20
references.pmid: 12402501
references.citation: PLoS One. 2012;7(1):e31120
references.pmid: 22295124
references.citation: Bioessays. 1998 Aug;20(8):615-26
references.pmid: 9780836
references.citation: Science. 2009 Aug 14;325(5942):834-40
references.pmid: 19608861
references.citation: Cancer Res. 2010 Feb 1;70(3):1053-62
references.pmid: 20103629
references.citation: JAMA. 2006 Dec 20;296(23):2823-31
references.pmid: 17179459
references.citation: PLoS One. 2012;7(1):e30815
references.pmid: 22303460
references.citation: Clin Cancer Res. 2007 Jan 1;13(1):152-60
references.pmid: 17200350
references.citation: Curr Opin Investig Drugs. 2008 Dec;9(12):1324-35
references.pmid: 19037839
references.citation: Cancer. 2008 Nov 1;113(9):2457-63
references.pmid: 18823034
references.citation: Nature. 1998 Jul 2;394(6688):88-92
references.pmid: 9665134
references.citation: J Urol. 2007 Jan;177(1):63-8; discussion 68-9
references.pmid: 17162001
references.citation: Cancer. 2008 Apr 15;112(8):1733-43
references.pmid: 18306389
references.citation: Drug Discov Today. 2007 Oct;12(19-20):853-9
references.pmid: 17933687
references.citation: Nat Rev Cancer. 2009 Aug;9(8):563-75
references.pmid: 19629071
references.citation: PLoS One. 2010 May 18;5(5):e10696
references.pmid: 20502531
references.citation: Int J Cancer. 1998 Feb 20;79(1):1-7
references.pmid: 9495349
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20350-5
references.pmid: 18077375
references.citation: Cancer Res. 2007 Apr 1;67(7):3145-52
references.pmid: 17409421
references.citation: Nat Rev Urol. 2010 May;7(5):245-57
references.pmid: 20448658
references.citation: Invest New Drugs. 2013 Feb;31(1):115-25
references.pmid: 22415798
references.citation: J Pathol. 2005 Feb;205(3):377-87
references.pmid: 15682440
references.citation: Hum Pathol. 2002 Jan;33(1):68-79
references.pmid: 11823975
references.citation: Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7192-7
references.pmid: 9207067
references.citation: Am Fam Physician. 2008 Aug 1;78(3):347-52
references.pmid: 18711950
references.citation: Exp Diabetes Res. 2012;2012:654904
references.pmid: 21977024
references.citation: Am J Surg Pathol. 1982 Oct;6(7):655-63
references.pmid: 7180965
references.citation: J Pathol. 2010 Jun;221(2):125-38
references.pmid: 20225241
references.citation: J Clin Oncol. 2004 Sep 15;22(18):3720-5
references.pmid: 15365068
references.citation: Trends Biochem Sci. 2003 Sep;28(9):488-94
references.pmid: 13678960
references.citation: Mayo Clin Proc. 2010 May;85(5):413-21
references.pmid: 20375178
references.citation: Cancer. 2011 Feb 15;117(4):758-67
references.pmid: 20922784
references.citation: Int J Cancer. 2009 Apr 15;124(8):1829-40
references.pmid: 19117056
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8511-5
references.pmid: 10411906
references.citation: Eur Urol. 2011 Oct;60(4):615-21
references.pmid: 21741761
references.citation: J Biol Chem. 1998 Feb 13;273(7):4135-42
references.pmid: 9461608
references.citation: BMC Res Notes. 2012 May 18;5:246
references.pmid: 22608002
references.citation: Kidney Int. 2002 Jul;62(1):237-44
references.pmid: 12081583
references.citation: Cancer. 2012 May 1;118(9):2338-66
references.pmid: 22460733
references.citation: J Urol. 2007 Jan;177(1):346-52
references.pmid: 17162089
references.citation: Nature. 1990 Oct 18;347(6294):645-50
references.pmid: 2129546
references.citation: Biochem Pharmacol. 2012 Apr 15;83(8):1021-32
references.pmid: 22209898
references.citation: Clin Cancer Res. 2008 Mar 1;14(5):1286-90
references.pmid: 18316545
references.citation: J Nephrol. 2006 Jul-Aug;19(4):429-38
references.pmid: 17048200
references.citation: Clin Cancer Res. 2008 May 15;14(10):3044-51
references.pmid: 18483370
references.citation: Dig Dis Sci. 2012 Apr;57(4):897-904
references.pmid: 22198701
references.citation: Nucleic Acids Symp Ser (Oxf). 2006;(50):257-8
references.pmid: 17150915
references.citation: Clin Cancer Res. 2003 Jan;9(1):327-37
references.pmid: 12538485
references.citation: J Am Soc Nephrol. 2005 Apr;16(4):1126-34
references.pmid: 15744000
references.citation: Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E198-206
references.pmid: 20484008
references.citation: Biochemistry. 2009 Jul 28;48(29):7019-31
references.pmid: 19526984
references.citation: PLoS One. 2011;6(10):e25625
references.pmid: 21998674
references.citation: BMC Res Notes. 2009 May 19;2:89
references.pmid: 19454029
references.citation: J Am Soc Nephrol. 2007 Oct;18(10):2704-14
references.pmid: 17898236
references.citation: Cancer Res. 1997 Oct 15;57(20):4593-9
references.pmid: 9377574
references.citation: Curr Pharm Des. 2002;8(25):2269-78
references.pmid: 12369855
references.citation: Lancet. 2008 Aug 9;372(9637):449-56
references.pmid: 18653228
references.citation: Eur Urol. 2009 Oct;56(4):690-8
references.pmid: 18930582
references.citation: J Clin Oncol. 2011 Dec 10;29(35):4688-95
references.pmid: 22025163
references.citation: Mol Cell Proteomics. 2009 May;8(5):971-85
references.pmid: 19164279
references.citation: J Cell Mol Med. 2009 Aug;13(8B):2376-2385
references.pmid: 18657224
references.citation: Urol Oncol. 2011 Sep-Oct;29(5):551-7
references.pmid: 21930086
references.citation: Cell. 1996 Mar 22;84(6):889-97
references.pmid: 8601312
references.citation: Cancer Res. 2006 Apr 1;66(7):3381-5
references.pmid: 16585157
references.citation: Lancet. 2011 Dec 3;378(9807):1931-9
references.pmid: 22056247
references.citation: Semin Cancer Biol. 2006 Feb;16(1):3-15
references.pmid: 16153857
references.citation: Anal Bioanal Chem. 2011 Jul;401(1):245-52
references.pmid: 21553213
references.citation: Cancer Res. 2012 Jul 15;72(14):3471-9
references.pmid: 22628425
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
references.pmid: 18663219
references.citation: Mol Carcinog. 2002 Aug;34(4):165-71
references.pmid: 12203367
references.citation: Nat Immunol. 2011 Aug 18;12(9):809-11
references.pmid: 21852775
references.citation: BMC Cancer. 2008 Dec 19;8:381
references.pmid: 19099586
references.citation: Clin Cancer Res. 2008 Apr 1;14(7):1926-30
references.pmid: 18381929
references.citation: Int J Biochem Cell Biol. 2002 Sep;34(9):1051-8
references.pmid: 12009300
references.citation: N Engl J Med. 2012 Jun 28;366(26):2517-9
references.pmid: 22658126
references.citation: Cancer Biol Ther. 2011 Nov 1;12(9):827-36
references.pmid: 21878748
references.citation: J Clin Oncol. 2010 Jul 1;28(19):3167-75
references.pmid: 20516446
references.citation: Nephrol Dial Transplant. 2009 Oct;24(10):3225-31
references.pmid: 19589786
references.citation: Clin Cancer Res. 2003 Nov 1;9(14):5195-204
references.pmid: 14613999
references.citation: Science. 1956 Feb 24;123(3191):309-14
references.pmid: 13298683